secwatch.observer — SEC 8-K summary
======================================

Issuer:     Design Therapeutics, Inc. (DSGN)
CIK:        0001807120
Form:       8-K
Filed at:   2023-06-01T23:59:59+00:00
Accession:  0001193125-23-159009
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Design Therapeutics shareholders re-elect three directors, ratify EY as auditor
-------------------------------------------------------------------------------

- Three Class II directors re-elected: Simeon George (47.5M for), Arsani William (49.0M), Deepa Prasad (49.0M); broker non-votes ~3.35M.
- Ratification of Ernst & Young as independent auditor for FY2023 approved: 52.5M for, 437 against, 123,262 abstentions.
- Annual meeting held May 31, 2023; 55,945,551 shares outstanding as of record date April 3, 2023.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1807120/000119312523159009/0001193125-23-159009-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1807120/000119312523159009/d348957d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-159009

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer